hydroxyl radical has been researched along with carboplatin in 2 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (carboplatin) | Trials (carboplatin) | Recent Studies (post-2010) (carboplatin) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 12,895 | 4,001 | 5,244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danford, AJ; Lippard, SJ; Tullius, TD; Wang, D; Wang, Q | 1 |
| Kiddle, JJ; Mezyk, SP; Swancutt, KL | 1 |
2 other study(ies) available for hydroxyl radical and carboplatin
| Article | Year |
|---|---|
Platinum anticancer drug damage enforces a particular rotational setting of DNA in nucleosomes.
Topics: Animals; Antineoplastic Agents; Carboplatin; CHO Cells; Cisplatin; Cricetinae; Cross-Linking Reagents; DNA Adducts; DNA Damage; DNA Footprinting; DNA Repair; Exodeoxyribonucleases; Hydroxyl Radical; In Vitro Techniques; Models, Molecular; Nucleic Acid Conformation; Nucleosomes | 2005 |
Free radical-induced redox chemistry of platinum-containing anti-cancer drugs.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Hydroxyl Radical; Oxidation-Reduction | 2007 |